Category Archives: News

Dr. Arsalan Alizadeh Receives DSM Translational Award

13th Jul, 2017

Diagnostic Services Manitoba is proud to announce that Dr. Arsalan Alizadeh was selected as the recipient of the DSM Translational Award at the College of Medicine Major Awards event that was held on June 7, 2017.




DSM SBH Pathology Lab Poised for Future Demands Following Complex Renovation

1st Jun, 2017

If you can imagine renovating your kitchen and bathroom at the same time and still living in the house, this is pretty much what Diagnostic Services Manitoba’s (DSM) St. Boniface Hospital (SBH) Pathology lab staff did for around a year. The result is a redesigned lab space that not only accommodates today’s workflow but which […]



Celebrating Med Lab Week, April 16-22, 2017

18th Apr, 2017

This week, April 16-22, 2017, is National Medical Laboratory Week in Canada. This celebratory week provides an opportunity for Medical Laboratory Technologists (MLTs) and Medical Laboratory Assistants (MLAs) to celebrate their role in health care and to raise public awareness of the contributions they make as part of the health care team.


2017 Research and Innovation Grant Recipients

28th Mar, 2017

Diagnostic Services Manitoba is pleased to announce the awardees in the 2017 Research and Innovation Grant Competition. The grants provide funding for research with a focus on knowledge translation leading to adoption and implementation of evidence- based clinical practice and patient outcome improvements.


TI Lab Contributes to Record Year for Kidney Donations in Manitoba

9th Mar, 2017

DSM’s Transplant Immunology Lab was extra busy last year – contributing to the record 57 kidney transplants that gave the gift of life to Manitobans through Manitoba’s Renal Transplant Program. The TI Lab already plays a very important role in the transplant of kidneys from both living and deceased donors, but work has expanded as […]


DSM ‘Best Lab Inspected in 25 Years’

14th Feb, 2017

Diagnostic Services Manitoba (DSM) was highly prepared for the unannounced accreditation inspection of its College of American Pathologists (CAP) accredited labs and anticipated high compliance but it could not have been predicted just how glowing inspectors’ feedback would be. A highly experienced laboratory professional remarked that DSM is the best lab system he has inspected […]


Call for 2017 DSM Summer Studentship Awards Program

31st Jan, 2017

Diagnostic Services Manitoba (DSM) Summer Studentship Awards program is seeking well-motivated students with strong academic records and/or previous research experience to participate in translational research, with preference given to laboratory medicine and diagnostic imaging research. The program is an excellent opportunity for students to work closely with diagnostic professionals and further their knowledge and skills […]


Dr. Arsalan Alizadeh Receives DSM Translational Award

July 13,17

Diagnostic Services Manitoba is proud to announce that Dr. Arsalan Alizadeh was selected as the recipient of the DSM Translational Award at the College of Medicine Major Awards event that was held on June 7, 2017.

Dr. Alizadeh accepting the Translational Award from Alissa Leforte, DSM Director of Laboratory Services

Dr. Alizadeh’s research on spinal cord regeneration following injury is considered groundbreaking both locally and internationally. Recognizing the extent of Dr. Alizadeh’s contributions to research, he was further awarded the Drewry Award for Excellence of Research in the Health Sciences at the awards event in June. The Drewry Award is the highest possible recognition for a top ranking student.

“DSM is committed to supporting research that is relevant to the diagnostic services we provide and that can help to create better outcomes for patients,” said Jim Slater, CEO of DSM. “Innovation is driven by research and it can change what the future of medicine looks like, ultimately improving patient care and recovery and creating a more sustainable health system. We are pleased to recognize the caliber of Dr. Alizadeh’s research with this award.”

The College of Medicine Awards are presented annually to graduate students completing their doctoral degrees. The awards consist of eight possible categories. Each award is worth $1,000 to the student, as well as recognition in the College of Medicine. All of the award winners demonstrate exemplary research skills along with findings that will make a significant impact on medicine and health outcomes.

More information on the CSHRF and awards is available at: http://umanitoba.ca/outreach/conferences/research_days/index.html

Dr. Arsalan Alizadeh – Bio:

Dr. Arsalan Alizadeh is a PhD candidate in Dr. Soheila Karimi’s laboratory in the Department of Physiology and Pathophysiology and the Regenerative Medicine Program within the Rady Faculty of Health Sciences at the University of Manitoba.  Arsalan also holds a Medical Degree from Iran.

Spinal cord injury (SCI) is a devastating condition that poses major socioeconomic burden to the patients’ families and Canadian health care system. Arsalan’s translational project has high implications for the treatment of SCI. The main challenge is that the tissue environment in the injured spinal cord is hostile for repair and regeneration due to severe inflammation and formation of scar tissue. Arsalan’s research has identified a molecule named Neuregulin-1, a growth factor produced by the cells in the normal spinal cord, as a therapy that can modulate inflammation and reduce scar formation in the injured spinal cord. Most importantly, this treatment strategy leads to improved functional recovery in preclinical models. His findings have recognized Neuregulin-1 as a viable therapeutic strategy for spinal cord repair and regeneration. Arsalan’s research has also garnered attention of the research community and selected as hot-topic in neurosciences by the Society for Neuroscience and earned many prestigious awards and scholarships. Arsalan’s future goal is to become a clinician scientist in the area of neurology. Receiving this award will help him to achieve his career goals.

Also posted in Research | Comments closed

New Provincial Health Organization – ‘Shared Health Services Manitoba’ (PHO-SHSM)

June 30,17

On behalf of the DSM Board and the organization, we want to provide clarification and reassurance that Diagnostic Services Manitoba continues to be Manitoba’s provincial diagnostic services provider and that you can reach us through the same channels you have in the past.

DSM will continue as the corporate, legal entity it has grown to be; in other words, DSM will continue “as usual” through the next nine months of transition to the new Provincial Health Organization – Shared Health Services Manitoba that was announced on June 27, 2017.

On April 1, 2018 DSM will become an integrated and integral part of PHO-SHSM. We expect that there will be no interruption to our ability to enter into agreements, contracts, and most importantly: 

without interruption to high quality, efficient, and effective

diagnostic services for Manitobans.

We are excited to become part of the broader provincial health organization and are proud that our organization will in many ways act as the foundation for Shared Health Services Manitoba. The new organization’s mission of improving patient care and providing coordinated clinical and business support to the province’s regional health authorities is very much in line with DSM’s own raison d’etre.

We look forward to continuing to work with all our stakeholders throughout this transition period and within the new provincial health organization post April 1, 2018.

In the complex world of health care, change can cause uncertainty: for our patients, public, health care providers and our business partners. Should you have any questions please don’t hesitate to connect with us through your normal contacts or at:

Diagnostic Services of Manitoba Inc. (DSM Inc.)
1502 – 155 Carlton St.
Winnipeg, MB R3C 3H8
Phone: (204) 926-8005 or 1-866-320-8796 (Toll-free Across Canada)
Fax: (204) 940-1761
Email: contact@dsmanitoba.ca
HR Inquiries: dsm_hr@dsmanitoba.ca
Accreditation Inquiries: DSMQuality@dsmanitoba.ca

We will continue to update our website with additional information as it comes available; thank you all for your patience and support.

Arlene Wilgosh, Board Chair
Jim Slater, CEO

Also posted in Medical Practitioners, Patients | Comments closed

Shaping the Future of Quality Improvements in Pathology 2017

June 28,17

Save the date for DSM’s fifth Shaping the Future Conference, September 22-23. MORE >

 

Posted in News | Comments closed

DSM SBH Pathology Lab Poised for Future Demands Following Complex Renovation

June 1,17

If you can imagine renovating your kitchen and bathroom at the same time and still living in the house, this is pretty much what Diagnostic Services Manitoba’s (DSM) St. Boniface Hospital (SBH) Pathology lab staff did for around a year.

The result is a redesigned lab space that not only accommodates today’s workflow but which was planned with the lab needs of the future already in mind. Space within the lab’s various departments and functions is now allocated and designed to best meet the needs of patient and staff safety as well as functionality and workflow. Each square foot is used to its full potential with specimens travelling the shortest and safest path through each pathology area to their final destination under a pathologist’s microscope.

“The number of cases is not going to decrease,” said Dr. Daniel Gomez, Pathologist and DSM’s SBH Laboratory Medical Director. “We need to prepare for the flow in ten years and this redesign gives us the capacity and flexibility to meet future demands.

Although the renovation to revamp almost the entire frontline pathology space was among one of the more complex that the SBH facility has experienced, all work was managed without impacting the turnaround time for patient results or referring a single sample to another facility due to the renovation process.
“We had a clear mandate and worked steadfastly throughout to ensure that patient care and workflow were not affected,” said Marilyne LeClair, Pathology Supervisor, acknowledging the positive attitudes and cooperation of her pathology team.

Laboratory Director Alissa Leforte acknowledged the amazing teamwork of pathologists, pathology staff and all SBH departments that worked alongside DSM leads to make the renovations possible. This includes SBH Project Management, Capital Planning and Facilities, Telecom, Housekeeping, IT and Protection Services.

“Thanks to the support and collaboration of everyone involved the renovations ran as smoothly as possible,” said Alissa. “This was key to our ability to maintain the expected level of pathology service to our physicians and patients throughout the project – not only at St. Boniface but at the many other health centres we serve across the province.”

Posted in News | Comments closed

Diagnostic Outpatient Service Interruption for Selkirk & Region Patients

May 30,17

DSM’s laboratory and diagnostic imaging services will be moving to the new Selkirk Regional Health Centre between June 5 and June 28 resulting in some interruptions to outpatient diagnostic services.

Services & Location Dates Affected Outpatient Service Impact
X-Ray Testing

Selkirk & District General Hospital

June 5-25 Outpatient X-ray services will be unavailable June 5-25.

If you require an X-ray before June 26, please visit neighbouring facilities in Arborg, Ashern, Beausejour, Eriksdale, Gimli, Lac du Bonnet, Pine Falls, Pinawa, Stonewall or Teulon.

For more information on location, please visit our Locations & Hours Page

Lab Blood/ Urine Collection

Selkirk & District General Hospital

Selkirk Medical Centre

June 23 The Labs at Selkirk & District General Hospital and Selkirk Medical Centre will be closed to outpatients June 23.

If you have any questions about how DSM diagnostic services may be affected during the move period, please call DSM Diagnostics in Selkirk at 204.785.7421.

Thank you for your patience and understanding while we work with the Interlake-Eastern Region to accommodate the move. We look forward to serving you at the new Selkirk Regional Health Centre, located at 120 Easton Drive (next driveway from the existing hospital) where all regular diagnostic services will resume June 28.

Please visit www.ierha.ca for more information on the opening of the new Selkirk Regional Health Centre.

Also posted in Patients | Comments closed

Celebrating Med Lab Week, April 16-22, 2017

April 18,17

This week, April 16-22, 2017, is National Medical Laboratory Week in Canada. This celebratory week provides an opportunity for Medical Laboratory Technologists (MLTs) and Medical Laboratory Assistants (MLAs) to celebrate their role in health care and to raise public awareness of the contributions they make as part of the health care team.

Often, the role of the lab professionals are hidden behind the closed doors of the lab, so the connection between the lab professional and patient care is not immediately apparent. But lab professionals are driven by an equal interest in science and caring for people so they put tremendous care into the work they do. MLTs are specially trained in educational programs for medical laboratory science. They may prepare specimens and conduct tests in a variety of disciplines such as Hematology, Immunology, Microbiology, Clinical Biochemistry & Genetics, Transfusion Medicine and Pathology.

DSM’s lab professionals serve communities across the province, striving to provide all Manitobans, no matter where they live, with high quality laboratory tests and timely results – or what DSM calls the “Results That Matter.” These results are important because they form the basis upon which doctors make diagnoses and treatment decisions.

To learn more about the role of lab professionals in health care, visit We’re Here for You, an educational website created by the Canadian Society for Medical Laboratory Science.

 

 

Also posted in Patients | Comments closed

2017 Research and Innovation Grant Recipients

March 28,17

Diagnostic Services Manitoba is pleased to announce the awardees in the 2017 Research and Innovation Grant Competition. The grants provide funding for research with a focus on knowledge translation leading to adoption and implementation of evidence- based clinical practice and patient outcome improvements.

This year, three projects received funding in the small grant category:

Creating a New Ovarian Cancer Pathology Resource for Research and Innovation in Manitoba

Principal Investigator: Dr. Mark Nachtigal (Biochemistry and Human Genetics, University of Manitoba and Senior Scientist, CancerCare Manitoba)
Co-Applicant: Dr. Cyrille Bicamumpaka (DSM/Pathology, University of Manitoba)

Project Summary:

The objective of this study is to build an ovarian cancer tissue microarray (TMA) that can be used as an innovative research tool to advance ovarian cancer research and diagnostic capabilities in Manitoba.

Scleraxis as a Biomarker for Cardiac Fibrosis in Hypertrophic Cardiomyopathy

Principal Investigator: Dr. Davindar Jassal (Radiology and Physiology, St Boniface Research Centre)

Co-Applicants: Drs. Ian Kirkpatrick (Radiology) and Michael Czubryt (Dept of Physiology, University of Manitoba)

Project Summary:

Sudden cardiac death (SCD) due to cardiovascular disease is a leading cause of death in Canada that is entirely preventable. In people younger than 40 years, hypertrophic cardiomyopathy (HCM) is a common cause of SCD. The objective of this study is to determine whether the scleraxis protein, which is a biomarker of cardiac fibrosis, is detectable and correlates with the incidence of cardiovascular disease in patients with HCM as seen in MRI images.

Prognostic Significance of Telomere Length in Follicular Lymphoma: A Population-Based Study

Principal Investigator: Dr. Michel Nasr (DSM, Pathology)

Co-Applicants: Drs. Arshad Ahsanuddin (DSM, Pathology) and Anamarija Perry (DSM, Dept of Pathology, University of Manitoba)

Project summary:

This study aims to evaluate telomere length (TL) in a group of de novo follicular lymphoma (FL) patients in Manitoba. The prognostic significance of telomere length in FL patients treated with chemotherapy, as well as the correlation of telomere length with other clinical parameters and immunohistochemical markers, will be assessed.

Also posted in Research | Comments closed

TI Lab Contributes to Record Year for Kidney Donations in Manitoba

March 9,17

DSM’s Transplant Immunology Lab was extra busy last year – contributing to the record 57 kidney transplants that gave the gift of life to Manitobans through Manitoba’s Renal Transplant Program. The TI Lab already plays a very important role in the transplant of kidneys from both living and deceased donors, but work has expanded as a result of the province’s latest donation option – donation after cardio-circulatory death (DCD), introduced in January 2016.

By offering DCD, the planned withdrawal of medical support that results in cardio-circulatory death, more families can now consider organ donation.  It is anticipated that DCD will increase donation rates by 20 to 25 per cent. In 2016, three DCD donations resulted in six individuals receiving new kidneys.

TI Charge Technologist Denise Pochinco says that the lab work-up for DCD is very similar to processes for Neurologically Determined Death (NDD) donors, however, organ suitability is not a sure thing and only 60-70% of potential DCD donors are able to donate. For DCD organs to be eligible, donors must reach death within a specific timeframe after the withdrawal of support. “It is difficult for our team to learn that the work they have started for a patient will not result in a much-needed transplant,” said Denise. “However, more times than not, successful transplantation results, making this method of giving very worthwhile.”

As with any transplant case timeliness of testing is critical. Once the organ is retrieved, the TI technologists perform final compatibility tests so recipients can get into the operating room as quickly as possible. Of course, the team is up to this task. They are used to the pressures and tight timelines required to cross match donors with recipients and monitor patients for signs of rejection.

“There are simply not enough kidneys available to meet the need. If the DCD program can increase transplant rates and improve the quality of life for more patients, it is a rewarding endeavour for the lab staff.”

———————————–

Today – March 9, 2017 – is World Kidney Day. World Kidney Day is a global awareness campaign aimed at raising awareness of the importance of our kidneys. To learn more visit the World Kidney Day website.

Also posted in Medical Practitioners, Patients | Comments closed

DSM ‘Best Lab Inspected in 25 Years’

February 14,17

Diagnostic Services Manitoba (DSM) was highly prepared for the unannounced accreditation inspection of its College of American Pathologists (CAP) accredited labs and anticipated high compliance but it could not have been predicted just how glowing inspectors’ feedback would be.

A highly experienced laboratory professional remarked that DSM is the best lab system he has inspected in his 25 years participating as a CAP inspector. His statement is a testament to the dedication of all staff and their persistent focus on doing the right thing for the patient.

With only an hour’s notice, CAP’s 13-person inspection team arrived January 23, spending three days performing a systemic review of lab operations at all of DSM’s CAP-accredited Laboratories including at the Health Sciences Centre and St. Boniface Hospital as well as the pathology laboratories at Seven Oaks General Hospital, Victoria Hospital, Grace Hospital and at Westman Laboratory in Brandon.

“The level of preparedness and compliance achieved is only possible when there is a daily commitment to quality and excellence on the part of each and every one of us,” said Jim Slater, DSM CEO. “We couldn’t be more proud of how our organization was represented.”

DSM was in compliance with over 99% of the checklist requirements. CAP’s prestigious stamp recognizes excellence not only at DSM’s CAP accredited facilities but, thanks to a systemic approach to quality, technical procedures and standardization, is also a reflection of the quality services and staff expertise in each of DSM’s 82 rural and urban labs.

“Provincially, we are following the same quality processes and we are working toward the same high standards,” said Dr. Amin Kabani, Chief Medical Officer. “With our strong foundation of quality, all of our labs are achieving the same high compliance.”

Strong technical and clinical support, safety and quality oversight, excellent medical leadership, robust documentation, and excellent use of data were noted by inspectors. Praise was given for our emphasis on quality through our auditing and corrective action processes as well as through our biennial self-inspection process. DSM’s effective competency tool was just one of several processes that inspectors identified as wanting to replicate within their own respective facilities.

Commendations were given within each provincial program area, a few of the highlights include: perfect score in Immunology; scope and depth of our Toxicology program; our impressive media preparation room and cutting edge technology of MALDI-TOF in Microbiology; province-wide integration of Transfusion Medicine policies and compliance by nursing staff in all partner organizations (RHAs and CCMB); and the high level of standardization and quality improvement within Pathology. Special mention was also made of our Choosing Wisely Manitoba efforts to reduce unnecessary testing and the level of collaboration with all our clinical partners to support appropriate use of our diagnostic services. Our Provincial Genomics Laboratory also received praise for its ‘flawless’ implementation of Next Generation Sequencing (NGS) and for being so well-organized and well-run. The lead inspector was particularly impressed with our national recognition for Choosing Wisely and Personalized Medicine.

Achieving this level of preparedness is the result of a strong foundation of quality, collaboration and teamwork and an everyday commitment to service excellence. DSM’s successful accreditation is due to a culture among our team of putting the patient first and to maintaining ‘accreditation-ready’ operations that comply with national and international standards and best practices and that go above and beyond the required accreditation of diagnostic facilities in Manitoba.

Posted in News | Comments closed

Call for 2017 DSM Summer Studentship Awards Program

January 31,17

Diagnostic Services Manitoba (DSM) Summer Studentship Awards program is seeking well-motivated students with strong academic records and/or previous research experience to participate in translational research, with preference given to laboratory medicine and diagnostic imaging research. The program is an excellent opportunity for students to work closely with diagnostic professionals and further their knowledge and skills in health related fields, and for supervisors to share their expertise and experience with the student.

DSM will award two students $5,000 each for the 3-month duration of the projects (May 15-Aug 15).

Potential projects, along with studentship application and guidelines, are available at: or visit DSM’s website at http://dsmanitoba.ca/research-and-innovation/summer-studentship-program.

Application deadline is: Friday, March 31, 2017

Please forward any enquiries to Kimberly Sawchuk at ksawchuk@dsmanitoba.ca.

Also posted in Research | Comments closed